Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The endolysosomal membrane is the lipid bilayer that delimits endosomes, lysosomes, and endolysosomes in eukaryotic cells. It serves as a dynamic barrier, mediates cargo sorting, regulates the acidic environment required for enzymatic degradation, and participates in cell signaling and organelle homeostasis[2][6][7]. The composition includes numerous integral and peripheral membrane proteins (e.g., LAMP family, transporters), glycoproteins, and is characterized by the presence of unique phospholipids and cholesterol content. While essential for cellular physiology, these membranes themselves are not considered discrete drug targets; rather, dysfunction of their integrity or associated proteins is linked to numerous diseases such as lysosomal storage disorders, neurodegenerative diseases, and infectious diseases[1][2][5].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endolysosomal membrane (null).